1. Overview
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency and Limitation
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
2.3. Market Sizing and Forecast
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.4. Assumptions for the Study
2.5. Limitations for the Study
3. Executive Summary
4. Factors Affecting Market Growth
4.1. Overview
4.2. Drivers
4.2.1. Increasing Cancer Prevalence
4.2.2. Rise in Awareness Regarding CAR T-cell Therapy
4.2.3. Increasing R&D Activities and Clinical Trials
4.3. Restraints
4.3.1. Complex Manufacturing Process
4.3.2. Adverse Effects of the Therapy
4.4. Opportunities
4.4.1. Scope in Emerging Economies
4.4.2. Innovation in Cell Therapies and Manufacturing Processes
4.5. Challenges
4.5.1. High Cost of Therapy
4.5.2. Lack of Skilled Professionals
4.6. Regulatory Analysis
4.7. Pricing Analysis
4.8. Pipeline Product Analysis
4.9. Patient Journey
4.10. Reimbursement Policies
4.11. Porters Five Forces Analysis
5. Global CAR T-cell Therapy Market & Trend Analysis—by Brand
5.1. Overview
5.2. Abecma (idecabtagene vicleucel)
5.3. Breyanzi (lisocabtagene maraleucel)
5.4. Kymriah (tisagenlecleucel)
5.5. Tecartus (brexucabtagene autoleucel)
5.6. Yescarta (axicabtagene ciloleucel)
5.7. Carvykti (ciltacabtagene autoleucel)
5.8. Other Brands
6. Global CAR T-cell Therapy Market & Trend Analysis—by Target Antigen
6.1. Overview
6.2. CD
6.3. BCMA
6.4. HER2
6.5. Other Target Antigens
7. Global CAR T-cell Therapy Market & Trend Analysis—by Indication
7.1. Overview
7.2. Lymphoma
7.3. Acute Lymphoblastic Leukemia
7.4. Multiple Myeloma
7.5. Acute Myeloid Leukemia
7.6. Other Indications
8. CAR T-cell Therapy Market & Trend Analysis—by Geography
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.3.6. Rest of Europe
8.4. Asia-Pacific
8.4.1. China
8.4.2. Japan
8.4.3. India
8.4.4. Rest of Asia-Pacific
8.5. Latin America
8.6. Middle East & Africa
9. Competitive Analysis
9.1. Overview
9.2. Key Growth Strategies
9.3. Vendor Market Positioning
9.4. Competitive Dashboard
9.4.1. Industry Leaders
9.4.2. Market Differentiators
9.4.3. Vanguards
9.4.4. Emerging Companies
9.5. Market Share Analysis/Market Ranking (2022)
10. Company Profiles (Business Overview, Financial Snapshot, Product Portfolio, Strategic Developments, and SWOT Analysis)
10.1. Novartis AG
10.2. bluebird bio, Inc.
10.3. Bristol-Myers Squibb Company
10.4. Caribou Biosciences, Inc.
10.5. Cartesian Therapeutics, Inc.
10.6. Pfizer Inc.
10.7. Cellectis S.A.
10.8. Celyad Oncology SA
10.9. Gilead Sciences, Inc.
10.10. Intellia Therapeutics, Inc.
10.11. Merck & Co., Inc.
10.12 Amgen Inc.
10.13. Inovio Pharmaceuticals, Inc.
10.14. OncoTherapy Science, Inc.
10.15. Other Companies
11. Appendix
11.1. Questionnaire
11.2. Available Customization
List of Tables
Table 1 Global CAR T-cell Therapy Market, by Brand, 2021–2030 (USD Million)
Table 2 Global CAR T-cell Therapy Market for Abecma (idecabtagene vicleucel), by Country/Region, 2021–2030 (USD Million)
Table 3 Global CAR T-cell Therapy Market for Breyanzi (lisocabtagene maraleucel), by Country/Region, 2021–2030 (USD Million)
Table 4 Global CAR T-cell Therapy Market for Kymriah (tisagenlecleucel), by Country/Region, 2021–2030 (USD Million)
Table 5 Global CAR T-cell Therapy Market for Tecartus (brexucabtagene autoleucel), by Country/Region, 2021–2030 (USD Million)
Table 6 Global CAR T-cell Therapy Market for Yescarta (axicabtagene ciloleucel), by Country/Region, 2021–2030 (USD Million)
Table 7 Global CAR T-cell Therapy Market for Carvykti (ciltacabtagene autoleucel), by Country/Region, 2021–2030 (USD Million)
Table 8 Global CAR T-cell Therapy Market, by Target Antigen, 2021–2030 (USD Million)
Table 9 Global CD Antigen Market, by Country/Region, 2021–2030 (USD Million)
Table 10 Global BCMA Antigen Market, by Country/Region, 2021–2030 (USD Million)
Table 11 Global HER2 Antigen Market, by Country/Region, 2021–2030 (USD Million)
Table 12 Global Other Target Antigens Market, by Country/Region, 2021–2030 (USD Million)
Table 13 Global CAR T-cell Therapy Market, by Indication, 2021–2030 (USD Million)
Table 14 Global CAR T-cell Therapy Market for Lymphoma, by Country/Region, 2021–2030 (USD Million)
Table 15 Global CAR T-cell Therapy Market for Acute Lymphoblastic Leukemia, by Country/Region, 2021–2030 (USD Million)
Table 16 Global CAR T-cell Therapy Market for Multiple Myeloma, by Country/Region, 2021–2030 (USD Million)
Table 17 Global CAR T-cell Therapy Market for Acute Myeloid Leukemia, by Country/Region, 2021–2030 (USD Million)
Table 18 Global CAR T-cell Therapy Market for Other Indications, by Country/Region, 2021–2030 (USD Million)
Table 19 North America: CAR T-cell Therapy Market, by Country, 2021–2030 (USD Million)
Table 20 North America: CAR T-cell Therapy Market, by Brand, 2021–2030 (USD Million)
Table 21 North America: CAR T-cell Therapy Market, by Target Antigen, 2021–2030 (USD Million)
Table 22 North America: CAR T-cell Therapy Market, by Indication, 2021–2030 (USD Million)
Table 23 U.S.: CAR T-cell Therapy Market, by Brand, 2021–2030 (USD Million)
Table 24 U.S.: CAR T-cell Therapy Market, by Target Antigen, 2021–2030 (USD Million)
Table 25 U.S.: CAR T-cell Therapy Market, by Indication, 2021–2030 (USD Million)
Table 26 Canada: CAR T-cell Therapy Market, by Brand, 2021–2030 (USD Million)
Table 27 Canada: CAR T-cell Therapy Market, by Target Antigen, 2021–2030 (USD Million)
Table 28 Canada: CAR T-cell Therapy Market, by Indication, 2021–2030 (USD Million)
Table 29 Europe: CAR T-cell Therapy Market, by Country/Region, 2021–2030 (USD Million)
Table 30 Europe: CAR T-cell Therapy Market, by Brand, 2021–2030 (USD Million)
Table 31 Europe: CAR T-cell Therapy Market, by Target Antigen, 2021–2030 (USD Million)
Table 32 Europe: CAR T-cell Therapy Market, by Indication, 2021–2030 (USD Million)
Table 33 Germany: CAR T-cell Therapy Market, by Brand, 2021–2030 (USD Million)
Table 34 Germany: CAR T-cell Therapy Market, by Target Antigen, 2021–2030 (USD Million)
Table 35 Germany: CAR T-cell Therapy Market, by Indication, 2021–2030 (USD Million)
Table 36 France: CAR T-cell Therapy Market, by Brand, 2021–2030 (USD Million)
Table 37 France: CAR T-cell Therapy Market, by Target Antigen, 2021–2030 (USD Million)
Table 38 France: CAR T-cell Therapy Market, by Indication, 2021–2030 (USD Million)
Table 39 U.K.: CAR T-cell Therapy Market, by Brand, 2021–2030 (USD Million)
Table 40 U.K.: CAR T-cell Therapy Market, by Target Antigen, 2021–2030 (USD Million)
Table 41 U.K.: CAR T-cell Therapy Market, by Indication, 2021–2030 (USD Million)
Table 42 Italy: CAR T-cell Therapy Market, by Brand, 2021–2030 (USD Million)
Table 43 Italy: CAR T-cell Therapy Market, by Target Antigen, 2021–2030 (USD Million)
Table 44 Italy: CAR T-cell Therapy Market, by Indication, 2021–2030 (USD Million)
Table 45 Spain: CAR T-cell Therapy Market, by Brand, 2021–2030 (USD Million)
Table 46 Spain: CAR T-cell Therapy Market, by Target Antigen, 2021–2030 (USD Million)
Table 47 Spain: CAR T-cell Therapy Market, by Indication, 2021–2030 (USD Million)
Table 48 Rest of Europe: CAR T-cell Therapy Market, by Brand, 2021–2030 (USD Million)
Table 49 Rest of Europe: CAR T-cell Therapy Market, by Target Antigen, 2021–2030 (USD Million)
Table 50 Rest of Europe: CAR T-cell Therapy Market, by Indication, 2021–2030 (USD Million)
Table 51 Asia-Pacific: CAR T-cell Therapy Market, by Country/Region, 2021–2030 (USD Million)
Table 52 Asia-Pacific: CAR T-cell Therapy Market, by Brand, 2021–2030 (USD Million)
Table 53 Asia-Pacific: CAR T-cell Therapy Market, by Target Antigen, 2021–2030 (USD Million)
Table 54 Asia-Pacific: CAR T-cell Therapy Market, by Indication, 2021–2030 (USD Million)
Table 55 China: CAR T-cell Therapy Market, by Brand, 2021–2030 (USD Million)
Table 56 China: CAR T-cell Therapy Market, by Target Antigen, 2021–2030 (USD Million)
Table 57 China: CAR T-cell Therapy Market, by Indication, 2021–2030 (USD Million)
Table 58 Japan: CAR T-cell Therapy Market, by Brand, 2021–2030 (USD Million)
Table 59 Japan: CAR T-cell Therapy Market, by Target Antigen, 2021–2030 (USD Million)
Table 60 Japan: CAR T-cell Therapy Market, by Indication, 2021–2030 (USD Million)
Table 61 India: CAR T-cell Therapy Market, by Brand, 2021–2030 (USD Million)
Table 62 India: CAR T-cell Therapy Market, by Target Antigen, 2021–2030 (USD Million)
Table 63 India: CAR T-cell Therapy Market, by Indication, 2021–2030 (USD Million)
Table 64 Rest of Asia-Pacific: CAR T-cell Therapy Market, by Brand, 2021–2030 (USD Million)
Table 65 Rest of Asia-Pacific: CAR T-cell Therapy Market, by Target Antigen, 2021–2030 (USD Million)
Table 66 Rest of Asia-Pacific: CAR T-cell Therapy Market, by Indication, 2021–2030 (USD Million)
Table 67 Latin America: CAR T-cell Therapy Market, by Brand, 2021–2030 (USD Million)
Table 68 Latin America: CAR T-cell Therapy Market, by Target Antigen, 2021–2030 (USD Million)
Table 69 Latin America: CAR T-cell Therapy Market, by Indication, 2021–2030 (USD Million)
Table 70 Middle East & Africa: CAR T-cell Therapy Market, by Brand, 2021–2030 (USD Million)
Table 71 Middle East & Africa: CAR T-cell Therapy Market, by Target Antigen, 2021–2030 (USD Million)
Table 72 Middle East & Africa: CAR T-cell Therapy Market, by Indication, 2021–2030 (USD Million)
Table 73 Recent Developments, by Company, 2020—2023
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
Figure 6 Market Size Estimation
Figure 7 Global CAR T-cell Therapy Market, by Brand, 2023 VS. 2030 (USD Million)
Figure 8 Global CAR T-cell Therapy Market, by Target Antigen, 2023 VS. 2030 (USD Million)
Figure 9 Global CAR T-cell Therapy Market, by Indication, 2023 VS. 2030 (USD Million)
Figure 10 CAR T-cell Therapy Market, by Region
Figure 11 Impact Analysis: CAR T-cell Therapy Market
Figure 12 Market Dynamics: CAR T-cell Therapy Market
Figure 13 Global CAR T-cell Therapy Market, by Brand, 2023 VS. 2030 (USD Million)
Figure 14 Global CAR T-cell Therapy Market, by Target Antigen, 2023–2030 (USD Million)
Figure 15 Global CAR T-cell Therapy Market, by Indication, 2023–2030 (USD Million)
Figure 16 Global CAR T-cell Therapy Market, by Geography, 2023–2030 (USD Million)
Figure 17 North America: CAR T-cell Therapy Market Snapshot
Figure 18 Europe: CAR T-cell Therapy Market Snapshot
Figure 19 Asia-Pacific: CAR T-cell Therapy Market Snapshot
Figure 20 Key Growth Strategies Adopted by Leading Players, 2020—2023
Figure 21 Competitive Dashboard: Chromatography Data Systems Market
Figure 22 CAR T-cell Therapy Market: Competitive Benchmarking, by Target Antigen
Figure 23 Novartis AG: Financial Overview (2022)
Figure 24 bluebird bio, Inc.: Financial Overview (2021)
Figure 25 Bristol-Myers Squibb Company: Financial Overview (2021)
Figure 26 Cellectis S.A.: Financial Overview (2021)
Figure 27 Caribou Biosciences, Inc.: Financial Overview (2021)
Figure 28 Pfizer Inc.: Financial Overview (2021)
Figure 29 Celyad Oncology SA: Financial Overview (2022)
Figure 30 Gilead Sciences, Inc.: Financial Overview (2022)
Figure 31 Intellia Therapeutics, Inc.: Financial Overview (2021)
Figure 32 Merck & Co., Inc.: Financial Overview (2022)
Figure 33 Amgen Inc.: Financial Overview (2022)
Figure 34 Inovio Pharmaceuticals, Inc.: Financial Overview (2022)
Figure 35 OncoTherapy Science, Inc.: Financial Overview (2022)
COVID-19
This report provides pre & post COVID-19 market estimates.